Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
223427
Q100: Staff unique ID 1 (q100id1)
Data file: p_do_1
Overview
Valid:
746
Invalid:
0
Type:
Discrete
Start:
1291
End:
1295
Width:
5
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 96 | 4 |
0.5%
|
|
| EN03 | 1 |
0.1%
|
|
| ER | 1 |
0.1%
|
|
| ER 02 | 4 |
0.5%
|
|
| ER 04 | 2 |
0.3%
|
|
| ER 06 | 5 |
0.7%
|
|
| ER 08 | 2 |
0.3%
|
|
| ER 10 | 7 |
0.9%
|
|
| ER 14 | 1 |
0.1%
|
|
| ER 15 | 2 |
0.3%
|
|
| ER 16 | 1 |
0.1%
|
|
| ER 19 | 3 |
0.4%
|
|
| ER 20 | 5 |
0.7%
|
|
| ER 23 | 1 |
0.1%
|
|
| ER 25 | 1 |
0.1%
|
|
| ER 26 | 1 |
0.1%
|
|
| ER 27 | 3 |
0.4%
|
|
| ER 3 | 1 |
0.1%
|
|
| ER 31 | 1 |
0.1%
|
|
| ER 34 | 1 |
0.1%
|
|
| ER 36 | 1 |
0.1%
|
|
| ER 37 | 1 |
0.1%
|
|
| ER 4 | 1 |
0.1%
|
|
| ER 58 | 1 |
0.1%
|
|
| ER 6 | 3 |
0.4%
|
|
| ER 62 | 1 |
0.1%
|
|
| ER 66 | 2 |
0.3%
|
|
| ER 72 | 1 |
0.1%
|
|
| ER 73 | 1 |
0.1%
|
|
| ER 75 | 1 |
0.1%
|
|
| ER 8 | 1 |
0.1%
|
|
| ER 82 | 1 |
0.1%
|
|
| ER 83 | 1 |
0.1%
|
|
| ER 86 | 1 |
0.1%
|
|
| ER-06 | 1 |
0.1%
|
|
| ER-09 | 1 |
0.1%
|
|
| ER-13 | 2 |
0.3%
|
|
| ER-16 | 2 |
0.3%
|
|
| ER01 | 5 |
0.7%
|
|
| ER02 | 7 |
0.9%
|
|
| ER03 | 4 |
0.5%
|
|
| ER05 | 3 |
0.4%
|
|
| ER06 | 5 |
0.7%
|
|
| ER07 | 8 |
1.1%
|
|
| ER08 | 4 |
0.5%
|
|
| ER09 | 6 |
0.8%
|
|
| ER10 | 15 |
2%
|
|
| ER11 | 3 |
0.4%
|
|
| ER13 | 8 |
1.1%
|
|
| ER14 | 24 |
3.2%
|
|
| ER15 | 5 |
0.7%
|
|
| ER16 | 3 |
0.4%
|
|
| ER17 | 2 |
0.3%
|
|
| ER18 | 12 |
1.6%
|
|
| ER19 | 2 |
0.3%
|
|
| ER20 | 5 |
0.7%
|
|
| ER22 | 1 |
0.1%
|
|
| ER24 | 13 |
1.7%
|
|
| ER25 | 2 |
0.3%
|
|
| ER27 | 2 |
0.3%
|
|
| ER28 | 1 |
0.1%
|
|
| ER3 | 3 |
0.4%
|
|
| ER32 | 3 |
0.4%
|
|
| ER33 | 5 |
0.7%
|
|
| ER34 | 4 |
0.5%
|
|
| ER47 | 1 |
0.1%
|
|
| ER5 | 3 |
0.4%
|
|
| GN30 | 6 |
0.8%
|
|
| GN33 | 2 |
0.3%
|
|
| GN35 | 1 |
0.1%
|
|
| PE | 3 |
0.4%
|
|
| PE 02 | 1 |
0.1%
|
|
| PE 07 | 1 |
0.1%
|
|
| PE 10 | 3 |
0.4%
|
|
| PE 11 | 1 |
0.1%
|
|
| PE 14 | 1 |
0.1%
|
|
| PE 15 | 26 |
3.5%
|
|
| PE 17 | 14 |
1.9%
|
|
| PE 18 | 1 |
0.1%
|
|
| PE 24 | 31 |
4.2%
|
|
| PE 3 | 1 |
0.1%
|
|
| PE 58 | 11 |
1.5%
|
|
| PE 59 | 12 |
1.6%
|
|
| PE 74 | 13 |
1.7%
|
|
| PE01 | 22 |
2.9%
|
|
| PE015 | 1 |
0.1%
|
|
| PE02 | 6 |
0.8%
|
|
| PE03 | 13 |
1.7%
|
|
| PE04 | 17 |
2.3%
|
|
| PE05 | 2 |
0.3%
|
|
| PE06 | 2 |
0.3%
|
|
| PE08 | 22 |
2.9%
|
|
| PE09 | 6 |
0.8%
|
|
| PE1 | 7 |
0.9%
|
|
| PE10 | 10 |
1.3%
|
|
| PE11 | 5 |
0.7%
|
|
| PE12 | 43 |
5.8%
|
|
| PE13 | 5 |
0.7%
|
|
| PE14 | 39 |
5.2%
|
|
| PE15 | 27 |
3.6%
|
|
| PE16 | 16 |
2.1%
|
|
| PE17 | 12 |
1.6%
|
|
| PE18 | 12 |
1.6%
|
|
| PE19 | 1 |
0.1%
|
|
| PE20 | 14 |
1.9%
|
|
| PE22 | 3 |
0.4%
|
|
| PE23 | 19 |
2.5%
|
|
| PE24 | 1 |
0.1%
|
|
| PE25 | 13 |
1.7%
|
|
| PE28 | 14 |
1.9%
|
|
| PE29 | 2 |
0.3%
|
|
| PE3 | 2 |
0.3%
|
|
| PE30 | 1 |
0.1%
|
|
| PE31 | 1 |
0.1%
|
|
| PE32 | 3 |
0.4%
|
|
| PE33 | 1 |
0.1%
|
|
| PE34 | 1 |
0.1%
|
|
| PE36 | 1 |
0.1%
|
|
| PE39 | 7 |
0.9%
|
|
| PE51 | 5 |
0.7%
|
|
| PE53 | 15 |
2%
|
|
| PE55 | 2 |
0.3%
|
|
| PE6 | 1 |
0.1%
|
|
| PE63 | 2 |
0.3%
|
|
| PE68 | 1 |
0.1%
|
|
| PE7 | 1 |
0.1%
|
|
| PE74 | 1 |
0.1%
|
|
| PE9 | 1 |
0.1%
|
|
| PE`5 | 1 |
0.1%
|
|
| SU02 | 2 |
0.3%
|
|
| SU05 | 4 |
0.5%
|
|
| SU07 | 2 |
0.3%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.